Nanomedicine in leishmaniasis: A promising tool for diagnosis, treatment and prevention of disease - An update overview

纳米医学 利什曼病 免疫系统 疾病 利什曼原虫 免疫学 医学 内脏利什曼病 热带疾病 纳米技术 计算机科学 材料科学 病理 寄生虫寄主 万维网 纳米颗粒
作者
João Paulo Assolini,Amanda Cristina Machado Carloto,Bruna Taciane da Silva Bortoleti,Manoela Daiele Gonçalves,Fernanda Tomiotto‐Pellissier,Paulo Emílio Feuser,Arthur Poester Cordeiro,Pedro Henrique Hermes de Araújo,Cláudia Sayer,Milena Menegazzo Miranda-Sapla,Wander Rogério Pavanelli
出处
期刊:European Journal of Pharmacology [Elsevier BV]
卷期号:923: 174934-174934 被引量:15
标识
DOI:10.1016/j.ejphar.2022.174934
摘要

Leishmaniasis is a neglected tropical disease that has a wide spectrum of clinical manifestations, ranging from visceral to cutaneous, with millions of new cases and thousands of deaths notified every year. The severity of the disease and its various clinical forms are determined by the species of the causative agent, Leishmania, as well as the host's immune response. Major challenges still exist in the diagnosis and treatment of leishmaniasis, and there is no vaccine available to prevent this disease in humans. Nanotechnology has emerged as a promising tool in a variety of fields. In this review, we highlight the main and most recent advances in nanomedicine to improve the diagnosis and treatment, as well as for the development of vaccines, for leishmaniasis. Nanomaterials are nanometric in size and can be produced by a variety of materials, including lipids, polymers, ceramics, and metals, with varying structures and morphologies. Nanotechnology can be used as biosensors to detect antibodies or antigens, thus improving the sensitivity and specificity of such immunological and molecular diagnostic tests. While in treatment, nanomaterials can act as drug carriers or, be used directly, to reduce any toxic effects of drug compounds to the host and to be more selective towards the parasite. Furthermore, preclinical studies show that different nanomaterials can carry different Leishmania antigens, or even act as adjuvants to improve a Th1 immune response in an attempt to produce an effective vaccine.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
大壮完成签到 ,获得积分10
刚刚
夏虫完成签到,获得积分10
1秒前
华仔的应助被zhou采纳,获得10
2秒前
Galaxy发布了新的文献求助50
2秒前
风吹麦浪的应助被怡然的海瑶采纳,获得10
2秒前
深情安青的应助被lyn采纳,获得10
2秒前
LamuQili完成签到,获得积分10
2秒前
MrZ1完成签到,获得积分10
3秒前
3秒前
amm完成签到,获得积分10
3秒前
丘比特的应助被李志采纳,获得10
3秒前
111发布了新的文献求助10
4秒前
4秒前
李进步完成签到,获得积分10
4秒前
丘比特的应助被kai采纳,获得10
4秒前
友好远望发布了新的文献求助10
4秒前
4秒前
5秒前
Ck完成签到,获得积分10
5秒前
爆米花的应助被钱百万采纳,获得10
5秒前
5秒前
5秒前
aaaa完成签到,获得积分10
5秒前
胖子完成签到,获得积分10
6秒前
xm发布了新的文献求助10
6秒前
SZA发布了新的文献求助10
6秒前
6秒前
华仔的应助被迈巴贺采纳,获得10
6秒前
6秒前
33发布了新的文献求助10
7秒前
7秒前
8秒前
8秒前
cobo发布了新的文献求助10
9秒前
wangmouren的应助被苗子采纳,获得10
9秒前
LIU发布了新的文献求助30
9秒前
直率飞柏发布了新的文献求助10
9秒前
无问西东完成签到,获得积分10
9秒前
思源的应助被绿兔子采纳,获得10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8162244
求助须知:如何正确求助?哪些是违规求助? 9556607
关于积分的说明 21735793
捐赠科研通 7752519
什么是DOI,文献DOI怎么找? 3427674
关于科研通互助平台的介绍 2552678
邀请新用户注册赠送积分活动 2472271